Cashu
Eli Lilly Expands Neuroscience Portfolio with Centessa Acquisition, Challenging Takeda’s Position
13 days ago
Stocks
Health Care
tak
Takeda Pharmaceutical Company
TOKYO STOCK EXCHANGE-TOKYO PRO MARKET: TAK
+0.02 (+0.14%)
17.875
USD
At close at Apr 15, 19:07 UTC
Latest Takeda Pharmaceutical Company News
thelincolnianonline.com
Research Analysts’ Upgrades for April 11th (AACPU, ABX, ACGCU, AEHR, AIT, AIXI, AMGN, AMWD, ANNA, ANTX)
4 days ago
cnbc.com
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
15 days ago
cnbc.com
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells
22 days ago
prnewswire.com
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
about 2 months ago
benzinga.com
Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children, Shows Potential To Address Treatment Gaps
about 2 months ago
benzinga.com
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer
about 2 months ago
prnewswire.com
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
2 months ago
prnewswire.com
BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator
4 months ago
prnewswire.com
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
4 months ago
benzinga.com
FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder
5 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.